Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

THERMO FISHER SCIENTIFIC

(TMO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Thermo Fisher Scientific : Prices $5.85 Billion Offering of Senior Notes

10/20/2021 | 03:22am EST


ę MT Newswires 2021
All news about THERMO FISHER SCIENTIFIC
12/08THERMO FISHER SCIENTIFIC : Press Release of Thermo Fisher Scientific Inc., dated December ..
PU
12/08THERMO FISHER SCIENTIFIC INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
12/08Thermo Fisher Scientific Completes Acquisition of PPD, Inc.
PR
12/06Merck, Thermo Fisher Partner Over Expanding Investigational Antiviral Drug Production F..
MT
12/06Canada to manufacture Merck COVID-19 antivirals if regulator approves
AQ
12/06Merck ties up with Thermo Fisher to make its COVID-19 pill in Canada
RE
12/06Merck Expands Covid-19 Antiviral Drug Production in Ontario
DJ
12/06INSIDER SELL : Thermo Fisher Scientific
MT
12/03UK Regulator Clears Thermo Fisher's Acquisition of PPD
MT
12/03British Competition Watchdog Clears Thermo Fisher's $21 Billion PPD Purchase
MT
More news
Analyst Recommendations on THERMO FISHER SCIENTIFIC
More recommendations
Financials (USD)
Sales 2021 37 181 M - -
Net income 2021 7 605 M - -
Net Debt 2021 25 683 M - -
P/E ratio 2021 33,5x
Yield 2021 0,15%
Capitalization 251 B 251 B -
EV / Sales 2021 7,45x
EV / Sales 2022 6,71x
Nbr of Employees 80 000
Free-Float 89,6%
Chart THERMO FISHER SCIENTIFIC
Duration : Period :
Thermo Fisher Scientific Technical Analysis Chart | TMO | US8835561023 | MarketScreener
Technical analysis trends THERMO FISHER SCIENTIFIC
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 22
Last Close Price 638,15 $
Average target price 668,10 $
Spread / Average Target 4,69%
EPS Revisions
Managers and Directors
Marc N. Casper Chairman, President & Chief Executive Officer
Stephen Williamson Chief Financial Officer & Senior Vice President
Ryan Snyder Chief Information Officer & Senior Vice President
Alan B. Sachs Chief Medical Officer
Karen E. Nelson Chief Scientific Officer
Sector and Competitors